magnolol has been researched along with benzo(a)pyrene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagase, H; Saito, J; Sakai, Y | 1 |
| Nagase, H; Saito, J; Shibuya, K | 1 |
| Fukushima, H; Nagase, H; Saito, J | 1 |
3 other study(ies) available for magnolol and benzo(a)pyrene
| Article | Year |
|---|---|
In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthracenes; Antimutagenic Agents; Benzo(a)pyrene; Biphenyl Compounds; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Imidazoles; Kinetics; Lignans; Male; Methylnitronitrosoguanidine; Microsomes, Liver; Molecular Structure; Mutagenicity Tests; Mutagens; Oxidoreductases; Quinoxalines; Rats; Rats, Sprague-Dawley; Salmonella typhimurium | 2006 |
Anti-clastogenic effect of magnolol on benzo(a)pyrene-induced clastogenicity in mice.
Topics: Animals; Benzo(a)pyrene; Biphenyl Compounds; Enzyme Activation; Lignans; Liver; Male; Mice; Mice, Inbred ICR; Micronucleus Tests; Mutagens | 2008 |
Anti-clastogenic effect of magnolol-containing Hange-koboku-to, Dai-joki-to, Goshaku-san, and Magnoliae Cortex on benzo(a)pyrene-induced clastogenicity in mice.
Topics: Animals; Antimutagenic Agents; Benzo(a)pyrene; Biphenyl Compounds; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Lignans; Magnolia; Medicine, Kampo; Mice; Mice, Inbred ICR; Micronucleus Tests; Mutagens; Plant Bark | 2009 |